8 results on '"Willoughby, Orion"'
Search Results
2. Ulk1 phosphorylation at S555 is not required for endurance training-induced improvements in exercise and metabolic capacity in mice.
- Author
-
Guan, Yuntian, Spaulding, Hannah, Yu, Qing, Zhang, Mei, Willoughby, Orion, Drake, Joshua C., and Yan, Zhen
- Subjects
AEROBIC capacity ,EXERCISE physiology ,PHOSPHORYLATION ,MICE ,GENOME editing - Abstract
Endurance exercise training improves exercise capacity as well as skeletal muscle and whole body metabolism, which are hallmarks of high quality-of-life and healthy aging. However, its mechanisms are not yet fully understood. Exercise-induced mitophagy has emerged as an important step in mitochondrial remodeling. Unc-51-like autophagy-activating kinase 1, ULK1, specifically its activation by phosphorylation at serine 555, was discovered as an autophagy driver and to be important for energetic stress-induced mitophagy in skeletal muscle, making it a potential mediator of the beneficial effects of exercise on mitochondrial remodeling. Here, we used CRISPR/Cas9-mediated gene editing and generated knock-in mice with a serine-to-alanine mutation of Ulk1 on serine 555. We now report that these mice displayed normal endurance capacity and cardiac function at baseline with a mild impairment in energy metabolism as indicated by an accelerated increase of respiratory exchange ratio (RER) during acute exercise stress; however, this was completely corrected by 8 wk of voluntary running. Ulk1-S555A mice also retained the exercise-mediated improvements in exercise capacity and metabolic flux. We conclude that Ulk1 phosphorylation at S555 is not required for exercise-mediated improvements of exercise and metabolic capacity in healthy mice. NEW & NOTEWORTHY: We have used CRISPR/Cas9-mediated gene editing to generate Ulk1-S555A knock-in mice to show that loss of phosphorylation of Ulk1 at S555 blunted exercise-induced mitophagy and mildly impairs energy metabolism during exercise in healthy mice. However, the knock-in mice retained exercise training-mediated improvements of endurance capacity and energy metabolism during exercise. These findings suggest that exercise-induced mitophagy through Ulk1 activation is not required for the metabolic adaptation and improved exercise capacity in young, healthy mice. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Neuromuscular Dysfunction Precedes Cognitive Impairment in a Mouse Model of Alzheimer’s Disease
- Author
-
Brisendine, Matthew H, primary, Nichenko, Anna S, additional, Bandara, Aloka B, additional, Willoughby, Orion S, additional, Amiri, Niloufar, additional, Weingrad, Zach, additional, Specht, Kalyn S, additional, Bond, Jacob M, additional, Addington, Adele, additional, Jones, Ronald G, additional, Murach, Kevin A, additional, Poelzing, Steven, additional, Craige, Siobhan M, additional, Grange, Robert W, additional, and Drake, Joshua C, additional
- Published
- 2023
- Full Text
- View/download PDF
4. Neuromuscular Dysfunction Precedes Cognitive Impairment in a Mouse Model of Alzheimer's Disease.
- Author
-
Brisendine, Matthew H, Nichenko, Anna S, Bandara, Aloka B, Willoughby, Orion S, Amiri, Niloufar, Weingrad, Zach, Specht, Kalyn S, Bond, Jacob M, Addington, Adele, Jones III, Ronald G, Murach, Kevin A, Poelzing, Steven, Craige, Siobhan M, Grange, Robert W, and Drake, Joshua C
- Subjects
NEUROMUSCULAR transmission ,ALZHEIMER'S disease ,SKELETAL muscle ,COGNITION disorders ,LABORATORY mice ,ACTION potentials ,ANIMAL disease models - Abstract
Alzheimer's disease (AD) develops along a continuum that spans years prior to diagnosis. Decreased muscle function and mitochondrial respiration occur years earlier in those that develop AD; however, it is unknown what causes these peripheral phenotypes in a disease of the brain. Exercise promotes muscle, mitochondria, and cognitive health and is proposed to be a potential therapeutic for AD, but no study has investigated how skeletal muscle adapts to exercise training in an AD-like context. Utilizing 5xFAD mice, an AD model that develops ad-like pathology and cognitive impairments around 6 mo of age, we examined in vivo neuromuscular function and exercise adapations (mitochondrial respiration and RNA sequencing) before the manifestation of overt cognitive impairment. We found 5xFAD mice develop neuromuscular dysfunction beginning as early as 4 mo of age, characterized by impaired nerve-stimulated muscle torque production and compound nerve action potential of the sciatic nerve. Furthermore, skeletal muscle in 5xFAD mice had altered, sex-dependent, adaptive responses (mitochondrial respiration and gene expression) to exercise training in the absence of overt cognitive impairment. Changes in peripheral systems, specifically neural communication to skeletal muscle, may be harbingers for AD and have implications for lifestyle interventions, like exercise, in AD. Graphical Abstract Integrated model for the development of neuromuscular dysfunction in the AD-like pathology of 5xFAD mice. (A) At 3 mo of age, nerve-stimulated muscle function is normal across genotypes and sexes. (B) By as early as 4 mo of age, nerve-stimulated muscle function declines, and (C) corresponds to impaired sciatic nerve function in 5xFAD mice. Peripheral neuromuscular dysfunction (D) corresponds to an altered mitochondrial and transcriptional response of skeletal muscle to exercise training. (E) These peripheral phenotypes of the early AD-like pathology of 5xFAD mice were present in the absence of overt cognitive decline, particularly in male mice. Created in Biorender. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Neuromuscular Dysfunction Precedes Cognitive Impairment in a Mouse Model of Alzheimer's Disease
- Author
-
Brisendine, Matthew H., Nichenko, Anna S., Bandara, Aloka B., Willoughby, Orion S., Amiri, Niloufar, Weingrad, Zach, Specht, Kalyn S., Bond, Jacob M., Addington, Adele, Jones III, Ronald G., Murach, Kevin A., Poelzing, Steven, Craige, Siobhan M., Grange, Robert W., Drake, Joshua C., Brisendine, Matthew H., Nichenko, Anna S., Bandara, Aloka B., Willoughby, Orion S., Amiri, Niloufar, Weingrad, Zach, Specht, Kalyn S., Bond, Jacob M., Addington, Adele, Jones III, Ronald G., Murach, Kevin A., Poelzing, Steven, Craige, Siobhan M., Grange, Robert W., and Drake, Joshua C.
- Abstract
Alzheimer's disease (AD) develops along a continuum that spans years prior to diagnosis. Decreased muscle function and mitochondrial respiration occur years earlier in those that develop AD; however, it is unknown what causes these peripheral phenotypes in a disease of the brain. Exercise promotes muscle, mitochondria, and cognitive health and is proposed to be a potential therapeutic for AD, but no study has investigated how skeletal muscle adapts to exercise training in an AD-like context. Utilizing 5xFAD mice, an AD model that develops ad-like pathology and cognitive impairments around 6 mo of age, we examined in vivo neuromuscular function and exercise adapations (mitochondrial respiration and RNA sequencing) before the manifestation of overt cognitive impairment. We found 5xFAD mice develop neuromuscular dysfunction beginning as early as 4 mo of age, characterized by impaired nerve-stimulated muscle torque production and compound nerve action potential of the sciatic nerve. Furthermore, skeletal muscle in 5xFAD mice had altered, sex-dependent, adaptive responses (mitochondrial respiration and gene expression) to exercise training in the absence of overt cognitive impairment. Changes in peripheral systems, specifically neural communication to skeletal muscle, may be harbingers for AD and have implications for lifestyle interventions, like exercise, in AD.
- Published
- 2023
6. Adrenergic restraint of blood flow and high‐altitude acclimatization
- Author
-
Willoughby, Orion S., primary
- Published
- 2022
- Full Text
- View/download PDF
7. Metabolic Impact of MKP-2 Upregulation in Obesity Promotes Insulin Resistance and Fatty Liver Disease
- Author
-
Fernando, Savanie, primary, Sellers, Jacob, additional, Smith, Shauri, additional, Bhogoju, Sarayu, additional, Junkins, Sadie, additional, Welch, Morgan, additional, Willoughby, Orion, additional, Ghimire, Nabin, additional, Secunda, Cassandra, additional, Barmanova, Marina, additional, Kumer, Sean C., additional, Min, Kisuk, additional, and Lawan, Ahmed, additional
- Published
- 2022
- Full Text
- View/download PDF
8. Metabolic Impact of MKP-2 Upregulation in Obesity Promotes Insulin Resistance and Fatty Liver Disease
- Author
-
Fernando, Savanie, Sellers, Jacob, Smith, Shauri, Bhogoju, Sarayu, Junkins, Sadie, Welch, Morgan, Willoughby, Orion, Ghimire, Nabin, Secunda, Cassandra, Barmanova, Marina, Kumer, Sean C., Min, Kisuk, Lawan, Ahmed, Fernando, Savanie, Sellers, Jacob, Smith, Shauri, Bhogoju, Sarayu, Junkins, Sadie, Welch, Morgan, Willoughby, Orion, Ghimire, Nabin, Secunda, Cassandra, Barmanova, Marina, Kumer, Sean C., Min, Kisuk, and Lawan, Ahmed
- Abstract
The mechanisms connecting obesity with type 2 diabetes, insulin resistance, nonalcoholic fatty liver disease, and cardiovascular diseases remain incompletely understood. The function of MAPK phosphatase-2 (MKP-2), a type 1 dual-specific phosphatase (DUSP) in whole-body metabolism, and how this contributes to the development of diet-induced obesity, type 2 diabetes (T2D), and insulin resistance is largely unknown. We investigated the physiological contribution of MKP-2 in whole-body metabolism and whether MKP-2 is altered in obesity and human fatty liver disease using MKP-2 knockout mice models and human liver tissue derived from fatty liver disease patients. We demonstrate that, for the first time, MKP-2 expression was upregulated in liver tissue in humans with obesity and fatty liver disease and in insulin-responsive tissues in mice with obesity. MKP-2-deficient mice have enhanced p38 MAPK, JNK, and ERK activities in insulin-responsive tissues compared with wild-type mice. MKP-2 deficiency in mice protects against diet-induced obesity and hepatic steatosis and was accompanied by improved glucose homeostasis and insulin sensitivity. Mkp-2−/− mice are resistant to diet-induced obesity owing to reduced food intake and associated lower respiratory exchange ratio. This was associated with enhanced circulating insulin-like growth factor-1 (IGF-1) and stromal cell-derived factor 1 (SDF-1) levels in Mkp-2−/− mice. PTEN, a negative regulator of Akt, was downregulated in livers of Mkp-2−/− mice, resulting in enhanced Akt activity consistent with increased insulin sensitivity. These studies identify a novel role for MKP-2 in the regulation of systemic metabolism and pathophysiology of obesity-induced insulin resistance and fatty liver disease.
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.